Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tang

Showing results (581-590 of 619) with videos related to

Pageof 62
Sort By:
Oncotarget|August 7, 2015
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cellsXin Liu, Xin Chen, Kiera Rycaj, et al.
JACC. Heart Failure|May 25, 2024
Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD StudyPalak Shah, Mary Looby, Matthew Dimond, et al.
Signal Transduction and Targeted Therapy|May 1, 2026
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancerAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Oncogene|April 23, 2013
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaL Xia, W Huang, D Tian, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Biofabrication|June 14, 2022
Co-axial printing of convoluted proximal tubule for kidney disease modelingA M van Genderen, M G Valverde, P E Capendale, et al.
Pathology Oncology Research : POR|January 1, 1996
Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects)Kenneth V Honn, Amer Aref, Yong Q Chen, et al.
Pathology Oncology Research : POR|January 1, 1996
Prostate Cancer Old Problems and New Approaches. Part III. Prevention and TreatmentKenneth V Honn, Amer Aref, Yong Q Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancerT C Chang, C H Lai, J H Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2021
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancerLingfan Xu, Yu Yin, Yanjing Li, et al.
Pageof 62

Showing results (581-590 of 619) with videos related to

Sort By:
Pageof 62
Oncotarget|August 7, 2015
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cellsXin Liu, Xin Chen, Kiera Rycaj, et al.
JACC. Heart Failure|May 25, 2024
Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD StudyPalak Shah, Mary Looby, Matthew Dimond, et al.
Signal Transduction and Targeted Therapy|May 1, 2026
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancerAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Oncogene|April 23, 2013
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaL Xia, W Huang, D Tian, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Biofabrication|June 14, 2022
Co-axial printing of convoluted proximal tubule for kidney disease modelingA M van Genderen, M G Valverde, P E Capendale, et al.
Pathology Oncology Research : POR|January 1, 1996
Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects)Kenneth V Honn, Amer Aref, Yong Q Chen, et al.
Pathology Oncology Research : POR|January 1, 1996
Prostate Cancer Old Problems and New Approaches. Part III. Prevention and TreatmentKenneth V Honn, Amer Aref, Yong Q Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancerT C Chang, C H Lai, J H Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2021
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancerLingfan Xu, Yu Yin, Yanjing Li, et al.
Pageof 62